Intelligent Analysis for Improving The Clinical Pathway of Lung Cancer
暂无分享,去创建一个
Yan Zhu | Weihui Dai | Fang Xie | Yan Kang | Wenbo Xu | Shuangshuang Dai | Yan Kang | W. Xu | Yan Zhu | Fang Xie | Shuangshuang Dai | Weihui Dai | Wenbo Xu
[1] L V Rubinstein,et al. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.
[2] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[3] C. Gridelli. Chemotherapy of advanced non small cell lung cancer in the elderly: an update. , 2000, Critical reviews in oncology/hematology.
[4] R. Yancik,et al. Aging and cancer in America. Demographic and epidemiologic perspectives. , 2000, Hematology/oncology clinics of North America.
[5] Kazumichi Yamamoto,et al. Surgical results of stage I non-small cell lung cancer: comparison between elderly and younger patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] J. Padilla,et al. [Stage I nonsmall cell lung cancer up to 3 cm in diameter. Prognostic factors]. , 2004, Archivos de bronconeumologia.
[7] M. Okada,et al. Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. , 2004, The Annals of thoracic surgery.
[8] H. Nakamura,et al. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis , 2005, British Journal of Cancer.
[9] Ara A Vaporciyan,et al. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. , 2005, Radiology.
[10] A. Rossi,et al. Chemotherapy of advanced non-small cell lung cancer in elderly patients. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] S. Ou,et al. Prognostic factors for survival of stage I non-small cell lung cancer (NSCLC) patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry (CCR) from 1989 to 2003: A4-07 , 2007 .
[12] Joe Y. Chang,et al. Clinical Investigation : Thoracic Cancer Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly , 2012 .
[13] G. Prisadov,et al. Size of tumour as a risk factor for malignancy in patients with peripheral pulmonary nodules , 2012, Folia medica.
[14] Joe Y. Chang,et al. Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly. , 2012 .
[15] J. Usuda,et al. Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[16] Yih-Leong Chang,et al. The Significance of Visceral Pleural Surface Invasion in 321 Cases of Non-Small Cell Lung Cancers with Pleural Retraction , 2012, Annals of Surgical Oncology.
[17] Y. Liu,et al. 91例小细胞肺癌预后的回顾性多因素分析 , 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.
[18] A. Sihoe,et al. Non-small cell lung cancer: when to offer sublobar resection. , 2014, Lung cancer.
[19] Frank C. Detterbeck,et al. The Eighth Edition Lung Cancer Stage Classification , 2017, Chest.
[20] Nishita Mehta,et al. Concurrence of big data analytics and healthcare: A systematic review , 2018, Int. J. Medical Informatics.
[21] Mohammad Nazir Ahmad,et al. Analyzing diffusion patterns of big open data as policy innovation in public sector , 2019, Comput. Electr. Eng..
[22] Panagiota Galetsi,et al. Big data analytics in health sector: Theoretical framework, techniques and prospects , 2020, Int. J. Inf. Manag..